Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
| Metric | GILD | RMD |
|---|
| Close | 170.68 | 229.94 |
| Market Cap | $213B | $32.6B |
| 1M | +14.51% | +4.00% |
| P/E (TTM) | — | 21.5 |
| Forward P/E | 22.0 | 18.0 |
| P/E 5-Yr Percentile | — | 11 |
| P/S | 7.0 | 5.8 |
| P/B | 17.9 | 5.0 |
| Dividend Yield | 3.98% | 1.25% |
| Latest Quarter Revenue | $8.3B | $1.4B |
| Revenue YoY | +6.8% | +5.9% |
| Gross Margin | 81.1% | 61.5% |
| Latest Quarter EPS | 1.94 | 2.92 |
| Avg Post-Earnings Move | ±3.8% | ±2.6% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.57% | 5.65% |
| 90-Day Net Insider Buying | −$15.9M | −$5.4M |
GILD · Revenue, Last 8 Quarters ($B)
RMD · Revenue, Last 8 Quarters ($B)
